(Q46634472)

23 December 2017

title

What is the optimal dosage of valganciclovir as preemptive therapy for CMV infection in allogeneic hematopoietic SCT? (English)

1 reference

23 December 2017

1 reference

3

1 reference

23 December 2017

author name string

A Candoni

1

1 reference

23 December 2017

E Simeone

2

1 reference

23 December 2017

C Pipan

4

1 reference

23 December 2017

R Fanin

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

21 April 2008

1 reference

23 December 2017

Bone Marrow Transplantation

published in

1 reference

23 December 2017

volume

42

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

207-208

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2008.98

exact match

0 references

cites work

Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.98

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.98

1 reference

23 December 2017

1 reference

23 December 2017